Breast Cancer
Breast cancer therapy trends show favorable physician response to published guidelines
Published in Women's Health Weekly, April 10th, 2006
A recent study published in the Journal of Clinical Oncology sought to "describe trends in the use of chemotherapy and hormonal therapy by nodal and estrogen receptor (ER) status in women with early-stage breast cancer."
L.C. Harlan and colleagues of the U.S. National Cancer Institute explained, "Cases were randomly sampled from the population-based Surveillance, Epidemiology and End Results (SEER) program and physician verified treatment was examined."
"A total of 9,481 women, aged 20 years and older, diagnosed with early-stage breast...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Breast cancer treatment disparities may exist due to ethnicity and insurance status - Colon Cancer
Colon cancer risk may be associated with central adiposity in women - Hypertension
Hypertension may be adversely affected by swimming therapy in older women - Ischemia
Myocardial perfusion is improved by tibolone therapy in women with ischemic heart disease - Obesity Research
Obesity risk in women may be related to socioeconomic status in childhood - Apoptosis
Estrogen induction protects cells from mediated apoptosis - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
